Logo-jnp
J Nephropathol. 2017;6(1): 30-42. doi: 10.15171/jnp.2017.06
PMID: 28042551        PMCID: PMC5106880

Original Article

Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern

Masoumeh Arabsalmani 1, Abdollah Mohammadian-Hafshejani 2, Mahshid Ghoncheh 3, Fatemeh Hadadian 4, Farhad Towhidi 5, Kamran Vafaee 5, Hamid Salehiniya 6,7 *

Cited by CrossRef: 28

1- Yu Y, Wang W, Xiong Z, Yang Z, Li J, Shen Y, Gu B. Comparison of Perioperative Outcomes Between Laparoscopic and Open Partial Nephrectomy for Different Complexity Renal Cell Carcinoma Based on the R.E.N.A.L. Nephrometry Score. CMAR. 2021;Volume 13:7455 [Crossref]
2- Rosero G, Pattarone G, Peñaherera A, Pilz J, Bödecker J, Perez M, Mertelsmann R, Lerner B, Follo M, Zhou J. Metronomic doses and drug schematic combination response tested within chambered coverslips for the treatment of breast cancer cells (JIMT-1). PLoS ONE. 2022;17(9):e0274911 [Crossref]
3- Seddiqui R, Kamal M, Yousufi H. Prevalence of Renal Cell Carcinoma in Samples Sent to the Pathology Department of Kabul University of Medical Sciences and City Medical Laboratory. Int J Cancer Manag. 2021;14(7) [Crossref]
4- Kalan Farmanfarma K, Mahdavifar N, Kiasara S, Hassanipour S, Salehiniya H. Determinants of mammography screening in Iranian women: A systematic review and meta-analysis. BD. 2022;41(1):279 [Crossref]
5- Kravtsov I, Solodky V, Pavlov A, Dzidzaria A, Fastovets S, Khoroshevskaya I. The role of obesity in patients with renal cell carcinoma. Onkourologiâ. 2023;19(1):17 [Crossref]
6- Kanesvaran R, Porta C, Wong A, Powles T, Ng Q, Schmidinger M, Ye D, Malhotra H, Miura Y, Lee J, Chong F, Pu Y, Yen C, Saad M, Lee H, Kitamura H, Bhattacharyya G, Curigliano G, Poon E, Choo S, Peters S, Lim E, Yoshino T, Pentheroudakis G. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma. ESMO Open. 2021;6(6):100304 [Crossref]
7- Pan K, Yao L, Chen Z, Sun J, Jia Z, Zhang J, Ling Z. KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma. Eur J Med Res. 2023;28(1) [Crossref]
8- Guo H, Zhao W, Wang A, Li M, Ma H, Wang F, Wang Q, Ba X. The value of sex-specific abdominal visceral fat as measured via CT as a predictor of clear renal cell carcinoma T stage. Adipocyte. 2021;10(1):285 [Crossref]
9- Allahqoli L, Mazidimoradi A, Momenimovahed Z, Rahmani A, Hakimi S, Tiznobaik A, Gharacheh M, Salehiniya H, Babaey F, Alkatout I. The Global Incidence, Mortality, and Burden of Breast Cancer in 2019: Correlation With Smoking, Drinking, and Drug Use. Front Oncol. 2022;12 [Crossref]
10- Chen B, Jiao Z, Yin X, Qian Z, Gu J, Sun H. Novel insights into biomarkers associated with renal cell carcinoma. Oncol Lett. 2018; [Crossref]
11- Pourhanifeh M, Hosseinzadeh A, Juybari K, Mehrzadi S. Melatonin and urological cancers: a new therapeutic approach. Cancer Cell Int. 2020;20(1) [Crossref]
12- Bai X, Yi M, Dong B, Zheng X, Wu K. The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017. Exp Hematol Oncol. 2020;9(1) [Crossref]
13- Guo H, Zhang Y, Ma H, Gong P, Shi Y, Zhao W, Wang A, Liu M, Sun Z, Wang F, Wang Q, Ba X. T-stage-specific abdominal visceral fat, haematological nutrition indicators and inflammation as prognostic factors in patients with clear renal cell carcinoma. Adipocyte. 2022;11(1):133 [Crossref]
14- Çolak R, Gültürk İ, Dinç G, Akdağ G, Yıldırım S, Yılmaz M, Tural D. The relationship between body mass index and survival in patients with renal cell carcinoma treated with nivolumab. Journal of Chemotherapy. 2025;:1 [Crossref]
15- Jhuang J, Chiang C, Su S, Yang Y, Lee W. Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis. Sci Rep. 2019;9(1) [Crossref]
16- Tian X, Zhang S, Zhang Q, Kang L, Ma C, Feng L, Li S, Li J, Yang L, Liu J, Qi Z, Shen Y. Resveratrol inhibits tumor progression by down-regulation of NLRP3 in renal cell carcinoma. The Journal of Nutritional Biochemistry. 2020;85:108489 [Crossref]
17- Lee C, Huang P, Hsieh Y, Chen Y, Tsai J. Melatonin combined with sorafenib synergistically inhibit the invasive ability through targeting metastasis-associated protein 2 expression in human renal cancer cells. 2022;34(2):192 [Crossref]
18- Chatterjee S, Paul N, Das A, Bank S, Bankura B, Sarkar K, Saha S, Malakar S, Choudhury S, Ghosh S, Das M. Investigating the association of VHL gene variants with disease risk and clinicopathological outcomes in ccRCC patients from West Bengal, India. Urologic Oncology: Seminars and Original Investigations. 2025; [Crossref]
19- Hassanipour S, Mohammadzadeh M, Mansour-Ghanaei F, Fathalipour M, Joukar F, Salehiniya H, Abdzadeh E, Samadani A, Nikbakht H, Arab-Zozani M. The Incidence of Hepatocellular Carcinoma in Iran from 1996 to 2016: a Systematic Review and Meta-analysis. J Gastrointest Canc. 2019;50(2):193 [Crossref]
20- Rha S, Choueiri T, Matveev V, Alyasova A, Hong S, Gordoa T, Gurney H, Bjarnason G, Buchler T, Pedrazzoli P, Takagi T, Park S, Lee J, Perini R, He C, McKenzie J, Eto M. Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial. Intl Journal of Cancer. 2023;153(6):1241 [Crossref]
21- Salari M, Kazemnejad A, Zayeri F. Clustering Asian Countries According to the Trend of liver cancer Mortality Rates: an Application of Growth Mixture Models. Iran Red Crescent Med J. 2017;19(8) [Crossref]
22- Aurilio G, Piva F, Santoni M, Cimadamore A, Sorgentoni G, Lopez-Beltran A, Cheng L, Battelli N, Nolè F, Montironi R. The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications. IJMS. 2019;20(22):5683 [Crossref]
23- Abdullah R, Kamarozaman N, Ab Dullah S, Aziz M, Aziza H. Health risks evaluation of mycotoxins in plant-based supplements marketed in Malaysia. Sci Rep. 2025;15(1) [Crossref]
24- Pan Y, Lee C, Lee L, Wen Y, Huang J, Yang S, Hsiao C. Incidence of Bladder Cancer in Type 2 Diabetes Mellitus Patients: A Population-Based Cohort Study. Medicina. 2020;56(9):441 [Crossref]
25- Wang D, Xiao Z, Shou J, Li C, Xing N. Comparison of laparoscopy and open radical nephrectomy of renal cell cancer. 2019;14(1):392 [Crossref]
26- El Hanbuli H, Ibrahim H, Soliman S. Immunohistochemical Expression of CD200 in Renal Cell Carcinoma. 2021;9(3):136 [Crossref]
27- Nowroozi M, Farkhani E, Hushmandi K, Amini E, Momeni S, Inanloo S, Sharifi L, Bokaie S. Continued Increase in Incidence of Kidney Cancer in Iran and its 31 Provinces. Int J Cancer Manag. 2024;17(1) [Crossref]
28- Hassanipour S, Namvar G, Fathalipour M, Salehiniya H. The incidence of kidney cancer in Iran: a systematic review and meta-analysis. BioMedicine. 2018;8(2):9 [Crossref]
29- Rezaei F, Mazidimoradi A, Rayatinejad A, Allahqoli L, Salehiniya H. Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data. Thoracic Cancer. 2023;14(18):1668 [Crossref]
30- Sahoo T, Desai C, Agarwal S, Rauthan A, Dhabhar B, Biswas G, Batra S, Saha R, Philip A, Agarwal V, Dattatreya P, Mohapatra P, Deshmukh C, Bhagat S, Patil S, Barkate H. ExPert ConsEnsus on the management of Advanced clear-cell RenaL celL carcinoma: INDIAn Perspective (PEARL-INDIA). BMC Cancer. 2023;23(1) [Crossref]